OKYO Pharma
phase trial design rota | OKYO Pharma
Company
Deck Type
Sector
Industry
Deck date
June 2023
Slide
20 of 25
Related slides by other companies
Chimerix
Investor Presentation
May 2023
pivotal phase action trial design primary overall survival day | Chimerix
NeuroSense Therapeutics
Investor Presentation
January 2024
phase trial | NeuroSense Therapeutics
argenx SE
Results
May 2021
phase trial in pemphigus focus on potential to drive fast onset and steroid sparing address | argenx SE
MAIA Biotechnology
Investor Presentation
October 2023
thio trial planned to expand best combination arms | MAIA Biotechnology
Other recent decks by OKYO Pharma
See all presentations (2 decks)
Shareholder Engagement
March 2020
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights